News

Applied Clinical Trials Online18h
Phase III MATTERHORN Trial Shows Imfinzi Combo Significantly Improves Event-Free Survival in Resectable Gastric and GEJ Cancers
Interim results from the global MATTERHORN study mark the first time an immunotherapy has demonstrated statistically ...
Applied Clinical Trials Online13h
HHS Cancels Moderna Grant for Late-Stage Development of mRNA Vaccine Candidate
Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...
Applied Clinical Trials Online16h
How Trump’s Most Favored Nation Policy Could Impact Funding for Clinical Development
In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...